| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice
|
Honda-Okubo, Yoshikazu
|
|
|
41 |
38 |
p. 5592-5602
|
artikel
|
| 2 |
A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults
|
Gunale, Bhagwat
|
|
|
41 |
38 |
p. 5614-5621
|
artikel
|
| 3 |
Applying the COM-B behaviour model to understand factors which impact school immunisation nurses’ attitudes towards designing and delivering a HPV educational intervention in post-primary schools for 15–17 year old students in Northern Ireland, UK
|
Flood, Terri
|
|
|
41 |
38 |
p. 5630-5639
|
artikel
|
| 4 |
A review of criteria strictness in “Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials”
|
Amai, Motoki
|
|
|
41 |
38 |
p. 5622-5629
|
artikel
|
| 5 |
Beyond the numbers: An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses
|
Amani, Adidja
|
|
|
41 |
38 |
p. 5572-5579
|
artikel
|
| 6 |
Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection
|
Liu, Bette
|
|
|
41 |
38 |
p. 5587-5591
|
artikel
|
| 7 |
Contributions of cost-effectiveness analyses (CEA) to influenza vaccination policy for older adults in Europe
|
Chicoye, Annie
|
|
|
41 |
38 |
p. 5518-5524
|
artikel
|
| 8 |
COVID-19 vaccine behaviour among citizens of the Métis Nation of Ontario: A qualitative study
|
Simms, Abigail J.
|
|
|
41 |
38 |
p. 5640-5647
|
artikel
|
| 9 |
Differences between DNA vaccine and single-cycle viral vaccine in the ability of cross-protection against viral hemorrhagic septicemia virus (VHSV) and infectious hematopoietic necrosis virus (IHNV)
|
Kim, So Yeon
|
|
|
41 |
38 |
p. 5580-5586
|
artikel
|
| 10 |
Distribution of serotypes causing invasive pneumococcal disease in older adults from high-income countries and impact of pediatric and adult vaccination policies
|
Grant, Lindsay R.
|
|
|
41 |
38 |
p. 5662-5669
|
artikel
|
| 11 |
DS-5670a, a novel mRNA-encapsulated lipid nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2: Results from a phase 2 clinical study
|
Toyama, Kaoru
|
|
|
41 |
38 |
p. 5525-5534
|
artikel
|
| 12 |
Editorial Board/Aims and Scope
|
|
|
|
41 |
38 |
p. IFC
|
artikel
|
| 13 |
Effectiveness of thirteen-valent pneumococcal conjugate vaccine to prevent serotype 3 invasive pneumococcal disease in Quebec in children, Canada
|
Deceuninck, Geneviève
|
|
|
41 |
38 |
p. 5486-5489
|
artikel
|
| 14 |
“EvoVax” – A rationally designed inactivated Salmonella Typhimurium vaccine induces strong and long-lasting immune responses in pigs
|
Lentsch, Verena
|
|
|
41 |
38 |
p. 5545-5552
|
artikel
|
| 15 |
Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves’ disease: An observational cohort study
|
Xu, Shichen
|
|
|
41 |
38 |
p. 5648-5654
|
artikel
|
| 16 |
Interventions for increasing the uptake of immunisations in healthcare workers: A systematic review
|
Tuckerman, Jane
|
|
|
41 |
38 |
p. 5499-5506
|
artikel
|
| 17 |
Prediction of highly pathogenic avian influenza vaccine efficacy in chickens by comparison of in vitro and in vivo data: A meta-analysis and systematic review
|
Mo, Jongseo
|
|
|
41 |
38 |
p. 5507-5517
|
artikel
|
| 18 |
Preliminary studies on the immunogenicity of a prime-and-trap malaria vaccine in nonhuman primates
|
Shears, Melanie J.
|
|
|
41 |
38 |
p. 5494-5498
|
artikel
|
| 19 |
Protection against symptomatic SARS-CoV-2 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original monovalent vaccines – A matched cohort study in France
|
Auvigne, Vincent
|
|
|
41 |
38 |
p. 5490-5493
|
artikel
|
| 20 |
Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naïve New Zealand cohort
|
Lavender, Brittany
|
|
|
41 |
38 |
p. 5535-5544
|
artikel
|
| 21 |
Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study
|
Moscara, L.
|
|
|
41 |
38 |
p. 5655-5661
|
artikel
|
| 22 |
The potential impact of a vaccine on Neisseria gonorrhoeae prevalence among heterosexuals living in a high prevalence setting
|
Padeniya, Thilini N.
|
|
|
41 |
38 |
p. 5553-5561
|
artikel
|
| 23 |
The safety and immunogenicity of a recombinant five-antigen Staphylococcus aureus vaccine among patients undergoing elective surgery for closed fractures: A randomized, double-blind, placebo-controlled, multicenter phase 2 clinical trial
|
Jiang, Xie-Yuan
|
|
|
41 |
38 |
p. 5562-5571
|
artikel
|
| 24 |
Trust and science: Public health’s home field advantage in addressing vaccine hesitancy and improving immunization rates
|
Pitts, Peter J.
|
|
|
41 |
38 |
p. 5483-5485
|
artikel
|
| 25 |
Variability of in vivo potency assays of whole-cell pertussis, inactivated polio, and meningococcal B vaccines
|
van Walstijn, Cerissa
|
|
|
41 |
38 |
p. 5603-5613
|
artikel
|
Tijdschrift beschrijving